Терапевтические возможности карбокситерапии при псориазе

Autor: Drogovoz, S., Kononenko, A., Shchokina, K., Belik, G., Shtroblya, A.

Publikováno v: Український біофармацевтичний журнал; № 4(57) (2018); 4-8
Ukraïns’kij bìofarmacevtičnij žurnal; № 4(57) (2018); 4-8
Украинский биофармацевтический журнал; № 4(57) (2018); 4-8

Topicality. Psoriasis is a chronic autoimmune disease characterized by changes in the growth and differentiation of the epidermis. 2-5 % of the population of the planet have psoriasis, and it is 30 % in the structure of skin diseases. The multifactor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::b7c6b0043163538f027884d6503f2046
http://ubphj.nuph.edu.ua/article/view/ubphj.18.192